Navigation Links
Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
Date:12/13/2012

INDIANAPOLIS, Dec. 13, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will stop one of three Phase 3 rheumatoid arthritis (RA) registration studies of tabalumab, an anti-BAFF monoclonal antibody, due to insufficient efficacy. The decision followed a planned interim futility analysis of the FLEX-M study investigating tabalumab, also known as LY2127399, for the treatment of patients with moderate-to-severe RA who had an inadequate response to methotrexate therapy. The decision was not based on safety concerns, and patients currently enrolled in other tabalumab RA studies will continue treatment.

The FLEX-M study was designed to support registration of tabalumab as a potential treatment for RA, including an assessment of its effect on structural progression. Lilly continues to evaluate tabalumab in two other Phase 3 RA registration studies as well as an open-label extension study and several other smaller studies. Lilly is suspending enrollment of new patients in the RA program until additional analysis from other ongoing RA studies is completed in early 2013. These other studies are in different patient populations.

Phase 3 studies for systemic lupus erythematosus are ongoing and will continue to enroll new patients. Currently, there is no evidence to suggest that efficacy results from the FLEX-M study in RA are indicative of potential efficacy in the lupus population. Lilly remains committed to the ongoing Phase 3 lupus program.

"The results of this study were unexpected given the data generated in earlier Phase II clinical studies of tabalumab," said Eiry Roberts, M.D., vice president of autoimmune product development at Lilly. "We remain committed to patients with rheumatoid arthritis and lupus and will move rapidly to evaluate the impact of these data on the overall tabalumab clinical development program. Beyond tabalumab,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly Provides Update on Next Steps for Solanezumab
2. Lilly to Expand Indianapolis Insulin Manufacturing Operations
3. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
4. Lilly Celebrates 18th Consecutive Year as One of Working Mothers 100 Best Companies
5. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
6. Lilly Announces Results From Lung Cancer Study
7. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
8. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
9. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
10. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
11. Lilly Announces Study Results Regarding Postmenopausal Women with Back Pain Caused by Vertebral Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Mass. , April 16, 2015  Hologic, ... important cervical cancer screening study i published ... a peer-reviewed journal of the American Cancer Society. ... Diagnostics and the University of Pittsburgh Medical Center, supports current ... which recommend that women 30-65 years of age ...
(Date:4/16/2015)... THOUSAND OAKS, Calif. , April 16, 2015 /PRNewswire/ ... will report its first quarter financial results on Tuesday, ... financial markets. The announcement will be followed by a ... PT. Participating in the call from Amgen will be ... officer, and other members of Amgen,s senior management team. ...
(Date:4/16/2015)... , April 16, 2015 Today, Kenneth ... Merck & Co., Inc., was elected chairman of the Board ... today,s Board meeting, PhRMA,s president and CEO John J. ... 1, 2016.  New Officers Elected to PhRMA ... and succeeds Ian C. Read , chairman and CEO ...
Breaking Medicine Technology:Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5
... FUJIFILM Medical Systems U.S.A., Inc. today announced that Synapse ... electronic health record (EHR) certification for Meaningful Use for radiology.  ... American Recovery and Reinvestment Act (ARRA) of 2009, approximately $1.5 ... EHRs and show that they use them in a meaningful ...
...  Volcano Corporation (NASDAQ: VOLC ), a leading ... to enhance the diagnosis and treatment of coronary and ... participating in the Roth Capital 24th Annual Orange County ... The presentation by John Dahldorf, chief financial officer, will ...
Cached Medicine Technology:FUJIFILM Receives Modular EHR Certification for Meaningful Use for Radiology 2FUJIFILM Receives Modular EHR Certification for Meaningful Use for Radiology 3
(Date:4/18/2015)... Patients who undergo radiation for a hematologic cancer ... but the disease is likely to differ in some ... Surviving Mesothelioma has just posted the details of this ... read it now. , Scientists from China, the ... who had both a hematologic cancer (like lymphoma or ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch ... at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... , In a turbulent world, people may find themselves ... always be their first move, but some situations can be ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable assisted ... on April 20 with a day full of activities ... soul. , The community, which is located at 605 ... all incomes, including those on Medicaid, who need some ... is observed every April and highlights the communities within ...
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic memory foam ... help a broader range of people plagued by pain. ... most common visitors to doctors. , “The ERGO-Pedic Comfort ... relieve sitting pain. Then, only a couple months after ... later, we began getting questions from those customers, asking ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2
... MONDAY, Feb. 20 (HealthDay News) -- Alcohol use disorders are ... reveals. The online, anonymous poll indicated that 15 percent ... nearly 14 percent of male surgeons and 26 percent of ... 12 percent figure typically cited for alcohol abuse rates among ...
... Feb. 19 (HealthDay News) -- Even though a colonoscopy is ... many people have unfounded worries about the test and avoid ... tool that allows us to see how healthy our insides ... and a gastroenterologist at Saint Louis University, said in a ...
... Substituting smokeless tobacco products can save smokers, lives, ... That is the message Brad Rodu, D.D.S., professor ... of Medicine and the Endowed Chair in Tobacco Harm ... at the Annual Meeting of the American Association for ...
... --- Alzheimer,s disease drugs now being tested in clinical ... new Northwestern Medicine research. A study with mice suggests ... neurons to be miswired and interfering with their ability ... from the scientist whose original research led to the ...
... SATURDAY, Feb. 18 (HealthDay News) -- Two factors -- a ... critical to quality of life for disabled elderly people, according ... seniors rate their quality of life as "fair to very ... seniors (white, black, Hispanic, and Chinese American) who were interviewed ...
... 17 (HealthDay News) -- Decades-old assumptions about the odds of reaching very ... for many seniors, a new study finds. At issue is how ... A team of researchers now believe that death rates continue to rise ... bit. The findings could lead to new estimates of life span, ...
Cached Medicine News:Health News:15% of U.S. Surgeons Report Drinking Problems in Survey 2Health News:15% of U.S. Surgeons Report Drinking Problems in Survey 3Health News:15% of U.S. Surgeons Report Drinking Problems in Survey 4Health News:Worries About Colonoscopy Unfounded: Study 2Health News:UofL research shows substituting with smokeless tobacco saves lives 2Health News:Alzheimer's drugs may have adverse side effects 2Health News: Disabled Elderly Say They Want Dignity, Control 2Health News:Living to 100 May Be Tougher Than You Think 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: